Open Label Pilot Study of Apremilast in Treatment of Rosacea

NCT01045551 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Erythematotelangiectatic Rosacea
Papulopustular Rosacea

Interventions

DRUG: Apremilast

Sponsor

Julian M. Mackay-Wiggan

Collaborators

[object Object]